Glenmark Pharmaceuticals Limited

Glenmark Life Sciences Limited

Kumar Hari Bhushan

Shekhar Bhaskar Bhirud

Prem Chand

Dilipkumar Jibhau Patil

Mandar Gopalkrushna Kulkarni

Sharad R Gore

Nandkumar Gaikwad

Krishna Baban Narawade

Rajendra C Jagdhane

Amol Anant Kadam

Shekhar Ashok Deshmukh

Avikumar Digambar Dabe

Pardeep Singh

Sanjay Shashikant Bhise

H M Veerabhadra Swamy

Hemant Harishchandra Kamble

Raghu Ram Suraparaju

Ganesh Chaudhari

Shrikant Prabhakar Keshav

Srinivas Reddy Sanikommu

Deepak Subhash Patil

Veerabhadra Swamy

Sunil Sudhakar Zhope

Shekhar Bhaksar Bhirud

Eknath Kundlik Khemnar

Shailesh Govind Ghadigaonkar

Amit Anant Thanedar

A process for the preparation of luliconazole and salts thereof is disclosed.

Process for preparation of luliconazole

The present invention relates to a process for the preparation of amorphous dapagliflozin. The present invention relates to 2,3-butanediol solvate of dapagliflozin and process for its preparation.

Process for preparation of dapagliflozin

The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol.

Process for preparation of ospemifene

Provided is a process for preparing azelaic acid.

Process for preparation of azelaic acid

The present invention relates to a process for the preparation of dimethyl fumarate, a compound of formula I, in a purity of at least 99.0% as determined by HPLC, containing less than 400 ppm of an anion of a mineral acid and less than 5 ppm of dimethyl maleate.

Process for preparation of dimethyl fumarate

Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban.

Process for the preparation of rivaroxaban

Growing community of inventors

Gurgaon, India

Kumar Hari Bhushan